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Abstract The influenza A M2 ion channel was expressed and 
activity characterized in Xenopus oocytes. Based on the activa- 
tion properties of the channels, a high throughput, non-electro- 
physiological screening assay was developed in order to identify 
novel inhibitors of the channel. This will facilitate discovery of 
novel agents to treat influenza viral infections. 
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1. Introduction 
A novel, acid activated ion channel, M2, was identified as a 
component of the influenza A virus [1]. Influenza A virus is a 
negative strand RNA virus, and is the primary viral agent for 
influenza [2]. The M2 channel is a viral encoded, single mem- 
brane spanning, protein of 97 amino acids with the amino 
terminus present on the extracellular side and a cytoplasmic tail 
[3-6]. The native protein is thought o form a functional ho- 
motetramer of, either, pairs of disulfide-linked dimers, or four 
disulfide linked monomers [7-10]. While potential N-linked 
glycosylation sites are present, they are not thought o be of 
functional significance [6]. In addition, the protein is acylated 
and phosphorylated, however, these modifications are not es- 
sential for activity [9,11-14]. The M2 protein is abundantly 
synthesized on the surface of the host cell, although only 5-10 
copies of the channel are present in the membrane of each 
virion [5,6,15,16]. 
The M2 channel is thought o be activated by low pH (~6.2) 
while the viral particle is present in the secondary endosome of 
the host cell [9,17-19]. Once the channel is activated, it is 
thought to pass protons to the interior of the viral particle 
allowing for the acid-induced changes which mediate viral un- 
coating resulting in the release of the viral genome [20]. A 
second physiological function has been indicated in the avian 
form of the virus where the M2 channel dissipates the pH 
gradient across the golgi membrane allowing the hemagglutinin 
protein, necessary for receptor binding, to emerge on the cell/ 
virion surface in the high pH conformation essential for infec- 
tivity in the next cycle [19,21-25]. Therefore, one target for 
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pharmacological intervention of influenza infections would be 
the M2 channel. Indeed, the only clinical anti-influenza A
agents available, amantadine and rimantadine, specifically 
block the M2 channel [1,26]. This channel is an optimal target 
since M2-1ike channels have not been identified in mammalian 
systems, nor does the M2 sequence share significant homology 
to known mammalian proteins [1]. Amantadine, while currently 
used prophylactically, does show CNS side effects in 5-10 per- 
cent of the population [27-30]. A second generation analog, 
rimantadine, reportedly has reduced CNS side effects, however, 
it does not appear to have an improved potency [31,32]. Aside 
from the CNS effects of these agents, it is also clear that viral 
resistance to these drugs can readily develop, and the resistance 
maps to the M2 channel [33,34]. Therefore, an improved agent 
would also seek to lower the probability of developing resis- 
tance. Since influenza/pneumonia is the sixth leading cause of 
death in the adult population of the US with influenza A being 
the main viral agent [2], there is a clear need for an antiviral 
agent which would improve upon the clinical profile of amanta- 
dine/rimantadine. 
One means to identify new chemical entities in the treatment 
of any disease is to undertake a screening effort of chemical and 
natural product libraries. Screening of a large number of sam- 
ples would be facilitated by a rapid and high throughput assay. 
This provides a unique challenge when looking for specific 
inhibitors of functional ion channels ince whole cell recording 
is not amenable to high throughput, and in many cases, binding 
assays do not utilize channels in their functional state. In addi- 
tion, the unique pH properties of the M2 channel make creating 
a stably transformed mammalian cell line extremely difficult. 
Since the Xenopus oocyte can tolerate xtreme pH ranges, we 
have utilized the system in the expression and study of the M2 
channel. Additionally, under the appropriate recording condi- 
tions, the M2 channel can pass sodium ions making the study 
of the channel feasible. We, therefore, have characterized the 
properties of the M2 channel when expressed in Xenopus 
oocytes and have developed a high throughput, functional 
screen. 
2. Materials and methods 
2.1. Expression of the M2 channel 
The M2 gene from influenza A/Udorn/72 was kindly supplied by Dr. 
Robert Lamb (Northwestern University) [1]. The vector was linearized 
with XbaI and runoff cRNA transcripts were made via Ambion's T7 
mMessage mMachine transcription kit per manufacturer's directions. 
Adult female Xenopus laevis (Xenopus I or Nasco) were maintained and 
oocytes harvested by published methods [35]. The oocytes were defolli- 
culated with 2 mg/ml collagenase (type 1A; Sigma) in Ca 2÷ free ND96 
[36] 1-2 h at room temperature (~20°C) and then washed with multiple 
buffer changes for up to 2 h in sND96. Healthy defolliculated stage 
IV/V/VI oocytes were collected, stored overnight in sND96 with 1% 
dialyzed fetal bovine serum (3 kDa cutoff; Sigma). The next day cells 
were injected with ~50 nl of a 1 mg/ml cRNA solution in RNAse-free 
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H20 and incubated 1 7 days at 18 19°C in sND96 with 1% serum at 
either pH 7.5 or 8.5, as indicated, prior to experimentation. 
2.2. Electrophysiology 
Macroscopic urrents were recorded using the two-microelectrode 
voltage clamp technique. Bath solution was ND96 with reduced (0.18 
mM) Ca z+ at the appropriate pH, and as indicated amantadine (Re- 
search Biochemicals Inc.) was added. Microelectrodes from KG-33 
glass (Garner Glass Co.) were pulled on a Narishige PB-7 pipet puller 
and then back filled with 3 M KCI with resulting resistances between 
0.2 2.0 M~. Membrane currents were recorded using either an 
Axoclamp2 (Axon) or a TEV 200 (Dagan) voltage clamp. Experiments 
were controlled and data collected on a CompuAdd 386 computer 
equipped with an analog interface (Labmaster) to the electrophysiologi- 
cal equipment. Experimental variables were manipulated, ata ana- 
lyzed, and graphically reproduced using pClamp software (Axon In- 
struments), Excel (Microsoft), Deltagraph Pro (Delta Point) and 
CorelDraw (Corel). 
2.3. Cell assay methods 
M2 expressing cells, 48 h post injection, were incubated in the appro- 
priate test conditions, as indicated, for -14 h at 18 19°C. In order to 
have sufficient buffering at pH 8.5 and 5.5 when test compounds were 
added, 10 mM MES (Fisher) was added to ND96 solutions in addition 
to the 5 mM HEPES. After the incubation, cells were scored visually 
under a dissecting microscope. 
2.4. Statistical methods" 
Analysis of Variance (ANOVA) type I was used to test statistical 
differences among the means of the different reatment groups. We 
assume that the differences among the group means are due to the fixed 
treatment effects determined by the experimenter. Multiple unplanned 
comparisons among the means from 16 replicates of cell assay data were 
made using the T-Method [37]. This a posteriori method allows for all 
pairwise comparisons of the group means to be performed. 
3. Results 
3.1. Expression of  influenza A virus M2 protein in Xenopus 
oocytes 
Cells were initially perfused in oocyte recording buffer, 
ND96 pH 7.5. The cells were clamped to a holding potential 
of -40 mV, and stepped for 3 s to test potentials between -60 
and -130 mV, allowing background current waveforms to be 
recorded. The M2 channels were activated by changing to 
ND96 at pH 5.5, and the voltage paradigm described above was 
repeated. Once steady state was achieved (30-60 s) the M2 
current was inhibited by changing the bath solution to ND96 
(pH 5.5) with 100 pM amantadine. Control injected oocytes 
(injected with cRNA for the cardiac Kvl .5 channel [38]) were 
studied in an identical manner. 
M2 current records obtained at a test potential of -120 mV 
are presented in Fig. 1. As shown, cells injected with M2 cRNA 
have robust inward currents at pH 5.5 which are blocked by 
100/,tM amantadine (Fig. IA). Although not shown, the M2 
currents activated at pH 5.5 are induced very rapidly upon 
switching the buffers and can be quickly deactivated by return- 
ing to the control ND96 at pH 7.5. The amantadine block is 
not rapidly reversible (data not shown). The cells injected with 
control Kvl .5 cRNA do not elicit a low-pH activatable current 
(Fig. 1B). 
The current~oltage r lationship for the activated M2 chan- 
nel presented as the mean (+S.E.M., n = 6) is shown in Fig. 2. 
Current amplitudes at each potential for each cell were meas- 
ured as the low pH induced current (the current amplitude 
recorded at pH 5.5 minus the current amplitude recorded at pH 
7.5). As shown, a low pH-activated current is only observed in 
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Fig. 1. Typical waveforms of M2 currents expressed in Xenopus 
oocytes. Cells were initially perfused in ND96, pH 7.5. Cells were 
clamped to a holding potential of -40 mV and current waveforms were 
evoked at a test potential of-120 mV for 3 s. (A) (1) Current waveform 
elicited from the oocyte in ND96 pH 7.5. (2) Current elicited from the 
same cell at pH 5.5. (3) Demonstrates the M2 current is inhibited by 
100/IM Amantadine in ND96 pH 5.5. (B) Xenopus oocytes injected 
with 50 ng of Kvl.5 cRNA were treated as above. (1) Current elicited 
from the oocyte at pH 7.5. (2) Current elicited from the same cell at 
pH 5.5. 
the cells injected with M2 cRNA, and the M2 current is inhib- 
ited beyond pH 7.5 baseline by the clinical agent amantadine 
presumably due to a small number of open channels at pH 7.5. 
In addition, the current-voltage relationship appears to be 
ohmic in this voltage region. 
3.2. pH activation profile of  the M2 channel 
In order to reduce the number of open channels, cells were 
initially perfused in ND96 pH 8.5. The cells were clamped to 
a holding potential of -40  mV and stepped for 3 s to a test 
potential of -110 mV, and current waveforms were obtained. 
The recording media was then switched to ND96 at different 
pHs (8.5-5.5 in 1.0 increments) and the voltage paradigm de- 
scribed above was repeated. Current amplitudes at each poten- 
tial for each cell were measured as the test pH induced current 
(the current amplitude recorded at variable pH minus the cur- 
rent amplitude recorded at pH 8.5). The mean (+ S.E.M.; n = 3) 
are presented as a normalized current versus pH relationship 
in Fig. 3. 
3.3. M2 cell assay 
It was noted that survival of oocytes expressing M2 channels 
was dramatically reduced (1-3 days) as compared to the 
oocytes expressing Kvl .5 channels (7-10 days). Also, as indi- 
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Fig. 2. Current-Voltage properties of M2 Channels. Cells were initially 
perfused in ND96, pH 7.5 and clamped to a holding potential of -40 
mV. Current waveforms were obtained from cells stepped for 3 s to test 
potentials between -60 and -130 mV in 10 mV increments at 10 s 
intervals. The recording media was switched to ND96 at low pH (5.5) 
and the voltage paradigm described above was repeated. The low pH- 
induced currents were then measured as described above in the presence 
of ND96, pH 5.5 with 100/IM Amantadine. In addition, control in- 
jected oocytes (with Kvl.5 cRNA) were examined following the same 
pH-voltage paradigm. Current amplitudes at each potential for each 
cell were measured at the end of the test pulse as the low pH induced 
current (the current amplitude recorded at pH 5.5 minus the current 
amplitude recorded at pH 7.5). The mean (+ S.E.M., n = 6) are pre- 
sented. 
cated in the preceding Figures, the pH profile of the channel 
suggested basal activity at pH 7.5. The next experiment, here- 
fore, investigated the survival of the cells at various buffered 
pHs. M2 channel expressing and control, non-injected cells 
(n = 12 for each condition), were incubated in ND96 at the 
following pHs: 8.5, 7.5, 6.5, and 5.5. After ~ 14 h, the cells were 
examined visually and scored, and the data is presented in 
Table 1. There was a dramatic rearrangement (condensation or 
loss) of the oocyte animal pole which correlated with the activa- 
tion of the M2 channel (see Fig. 4 below). When visually scor- 
ing, this rearrangement was termed cell 'death'.' 
The next set of experiments illustrated that the M2 specific 
cell 'death' can be prevented in a reproducible, dose-dependent 
manner by the presence of  amantadine. Fig. 4 presents repre- 
sentative examples of M2 expressing oocytes in which the 
oocyte animal pole undergoes a condensation and eventual 
elimination via the chronic activation of the M2 channel; this 
rearrangement was blocked by the presence of amantadine. 
Table 1 
pH dependence of cell survival 
pH Survival control Survival M2 
8.5 12 11 
7.5 12 11 
6.5 12 2 
5.5 12 0 
Assay performed as described in section 2. The time course of the 
experiment was 14 h. 12 cells, either non-injected or M2 injected, were 
used for each condition. 
Similar results were obtained with rimantadine (data not 
shown). Data for a total of 16 assays is presented in Fig. 5, and 
shows that cells are protected in a dose-dependent fashion by 
amantadine. No significant difference (P < 0.01) was seen be- 
tween the permissive (pH 8.5) control and the highest drug (pH 
5.5, 10/zM amantadine) treatment groups. Also, the negative 
control group (pH 5.5, 0 / tM amantadine) and the lowest drug 
(pH 5.5, 1 /,tM amantadine) treatment were not significantly 
different (P < 0.01) from each other. Whereas, the intermediate 
(pH 5.5, 5 / IM amantadine) treatment is significantly different 
(P < 0.01) from all other treatments. 
4. Discussion 
The M2 ion channel provides an amenable target o develop 
new classes of inhibitors for pharmaceutical intervention of 
influenza A infections. This channel appears to be unique to the 
viral genome, as low stringency Southern analysis of the human 
genome was negative ([1] R. Forgey, unpublished observa- 
tions]. The channel is readily activated at low pH when ex- 
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Fig. 3. pH Induction of the M2 Ion Channel. Cells were perfused in 
ND96, pH 8.5. The cells were clamped to a holding potential o f -40 
mV and were stepped for 3 s to a test potential of-110 mV, and current 
waveforms were obtained. The recording media was then switched to 
ND96 at different pHs (5.5-7.5 in 1.0 increments) and the voltage 
paradigm described above was repeated. Current amplitudes at the test 
potential for each cell were measured as the test pH induced current at 
the end of the test pulse (the current amplitude recorded at variable pH 
minus the current amplitude recorded at pH 8.5). Current amplitudes 
for each cell were normalized to the current evoked at the test potential 
at pH 8.5. The mean normalized current (+ S.E.M.; n = 3) are presented 
as a function of pH. 
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Fig. 4. M2 cell assay. Cells were incubated for 14 h as described in section 2. (A) M2 injected cells at pH 8.5; (B) M2 injected cells at pH 5.5; 
(C) Non-injected cells at pH 5.5; (D) M2 injected cells at pH 5.5 with 1 ,uM amantadine; (E) M2 injected cells at pH 5.5 with 5/IM amantadine; 
(F) M2 injected cells at pH 5.5 with 10/~M amantadine. Aspresented, cells shown in panels A, C, and F are 'viable'. While preliminary earrangement 
of the animal pole is evident in panel E, the cells are scored 'viable'. Cells in panels B and D are scored 'dead'. 
pressed in Xenopus oocytes, and pharmacologically, can be 
inhibited by the clinical agents amantadine and its closely re- 
lated analog, rimantadine. While these agents are used clini- 
cally, both show some level of CNS side effects, likely due at 
least in part to the interaction of the adamantine class of chem- 
istry with NMDA receptors [39~ 1]. Therefore, adifferent class 
of inhibitors could result in an ion channel blocker with greater 
specificity and a reduced side effect profile. 
The Xenopus oocyte expression system is widely used for the 
expression and study of ion channels. Data presented here 
characterizing the electrophysiological properties of the M2 
channel indicate the channel is activated as pH is lowered, and 
in addition, the cellular assay also indicates that the pH induced 
cell 'death' directly correlates with the pH activation properties 
of the M2 channel. We believe that oocyte 'death' in the assay 
is likely due to the continual influx of Na ÷ ions into the cell. 
Increasing the sodium concentration from 96 mM to 150 mM 
decreases the time course of 'death' (K. Giffin, unpublished 
observation). The ability of amantadine/rimantadine to pr vent 
cell 'death' correlates with the ability of amantadine to block 
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Fig. 5. Reproducibility of cell survival in the assay with Tuckey's 99% confidence intervals. Ten cells, either non-injected, or M2 injected were used 
for each condition in each replicate. Cells were cultured as described in section 2. Data were collected for 16 assays. Multiple unplanned comparisons 
among means were made by the T-Method (a = 5, n = 16. No significant difference (p ~< 0.01) was seen between the pH 8.5 and pH 5.5, 10/tM 
amantadine treatment groups. Also, the pH 5.5, 0/.tM amantadine and pH 5.5, 1/.tM amantadine treatments were not significantly different (p ~< 0.01 )
from each other. Whereas, the pH 5.5, 5/.tM amantadine treatment is significantly different (P ~< 0.01) from all other treatments. *Significantly 
different at p ~< .01; (s) not significantly different p ~< 0.01). 
the channel. As reported by Wang et. al. [26], the calculated 
IC5o of amantadine for the Udorn M2 channel is ~0.3 pM,  and 
the block has a very slow onset. The data presented here sug- 
gests that 1/IM is not protective, however, it appears likely that 
most, if not all, M2 channels need to be blocked in order for 
cells to 'survive'. This correlates with a calculated IC90 of~ 5/tM 
(R. Forgey, unpublished observation). 
Electrophysiological recordings are not practical in a screen 
involving millions of compounds, however, a screen based 
upon rapid visual inspection of cells is amenable to such an 
endeavor. Indeed, we have screened greater than ten thousand 
test substances a week against the M2 channel, and also 
screened against the clinically relevant amantadine resistant 
channels (results will be reported in the future). Since each 
oocyte requires manual injection of the cRNA,  it likely would 
have been more time efficient to screen this number of com- 
pounds in an automated system with an M2 expressing mam- 
malian cell line. This has not, however, been achievable. The 
M2 protein is basally activated at physiological pH, 7.0-7.5, 
and therefore, it appears that the production of a stable M2, 
high level expressing mammalian cell line is improbable. With 
the present assay, we can be assured that the channels are 
functional and inhibition of cell 'death', is thereby, a conse- 
quence of block the M2 channel. 
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